Grandclément, C., Estoppey, C., Dheilly, E., Panagopoulou, M., Monney, T., Dreyfus, C., . . . Sammicheli, S. (2024). Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma. Springer Nature.
Chicago Style (17th ed.) CitationGrandclément, C., et al. Development of ISB 1442, a CD38 and CD47 Bispecific Biparatopic Antibody Innate Cell Modulator for the Treatment of Multiple Myeloma. Springer Nature, 2024.
MLA (9th ed.) CitationGrandclément, C., et al. Development of ISB 1442, a CD38 and CD47 Bispecific Biparatopic Antibody Innate Cell Modulator for the Treatment of Multiple Myeloma. Springer Nature, 2024.
Warning: These citations may not always be 100% accurate.